|
Prospective Oral HPV and Risk of Head and Neck Cancers
|
5R21CA152785-02
|
$181,341
|
$181,341
|
BURK, ROBERT
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Persistent HPV in Women at Risk for Cervix Cancer
|
5U01CA078527-15
|
$567,757
|
$283,879
|
BURK, ROBERT
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$413,316
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$27,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$27,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$8,250
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
microRNA expression profiling of benign breast tissue and breast cancer risk
|
5R01CA142942-03
|
$738,155
|
$738,155
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
|
5K24CA139054-03
|
$167,705
|
$167,705
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort
|
5R01CA085178-13
|
$814,047
|
$814,047
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Influence of Fasting Status and Specimen Processing Time on Adipokine Levels
|
5R03CA143956-02
|
$57,016
|
$57,016
|
Strickler, Howard
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
International Case Control Study of Malignant Glioma
|
7R01CA139020-03
|
$3,914,658
|
$3,914,658
|
Bondy, Melissa
|
BAYLOR COLLEGE OF MEDICINE
|
|
Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status
|
5R03CA150027-02
|
$78,250
|
$78,250
|
Kaipparettu, Benny
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$8,287
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$15,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$586,952
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genomic Approaches to Defining Inherited Basis of Childhood Cancer
|
5R01CA138836-03
|
$433,740
|
$433,740
|
PLON, SHARON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Infection and Inflammation in Adult Gliomas
|
5K07CA131505-05
|
$135,445
|
$135,445
|
Scheurer, Michael
|
BAYLOR COLLEGE OF MEDICINE
|
|
Training Program in Pediatric Cancer Epidemiology and Control
|
5R25CA160078-02
|
$387,302
|
$135,556
|
SPITZ, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-17
|
$332,512
|
$332,512
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
Gene Polymorphisms in Relation to Cancer in Black Women
|
5R01CA098663-07
|
$581,614
|
$290,807
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
1UM1CA164974-01A1
|
$2,196,670
|
$2,196,670
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular biomarkers of airway and lung linking COPD and Lung Cancer
|
5R01CA164783-02
|
$535,797
|
$535,797
|
SPIRA, Avrum
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma
|
5R01CA149445-02
|
$549,324
|
$274,662
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-21
|
$1,813,397
|
$906,699
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Pathoepidemiology of Endometrial Cancer Risk
|
2R01CA082838-10A1
|
$359,654
|
$359,654
|
devivo, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Circulating fatty acids and breast cancer risk: a prospective study
|
1R01CA160246-01A1
|
$358,299
|
$358,299
|
Eliassen, A. Heather
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Oxidative Stree, Antioxidants and Risk of Breast Cancer: A Prospective Analysis
|
5R01CA131218-04
|
$557,634
|
$557,634
|
Eliassen, A. Heather
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
5P50CA093683-10
|
$2,300,000
|
$230,000
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Plasma Lipid Markers and Cancer Risk
|
1R03CA159399-01A1
|
$88,104
|
$88,104
|
Lin, Jennifer
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Predictors of Mammary Gland Development & Breast Fibroglandular Volume at puberty
|
1R01CA158313-01A1
|
$304,091
|
$152,046
|
MICHELS, KARIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular signatures of melanoma histology and progression: A Population Based A
|
5R01CA137365-04
|
$287,421
|
$287,421
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-13
|
$4,908,989
|
$638,169
|
Stampfer, Meir
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Growth Factors and Lethal Prostate Cancer Signature
|
5R01CA141298-03
|
$563,130
|
$563,130
|
Stampfer, Meir
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Whole Genome Association Study of Mammographic Density
|
5R01CA131332-04
|
$373,231
|
$373,231
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Growth Hormones and Breast Cancer Risk
|
5R01CA138580-03
|
$421,876
|
$421,876
|
Tworoger, Shelley
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Integrating Genetics of Gene Expression into Pathway Analysis for Melanoma GWAS
|
1R03CA167741-01
|
$97,615
|
$97,615
|
Zhang, Mingfeng
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Epidemiology of Molecular Alterations in Mesothelioma
|
5R01CA126939-05
|
$470,931
|
$235,466
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
Fresno State-SBCC Partnership: Cancer Research & Training for Central PA (1 of 2)
|
5P20CA138025-03
|
$242,662
|
$80,078
|
ZELEZNY, LYNNETTE
|
CALIFORNIA STATE UNIVERSITY FRESNO
|
|
Breast Cancer Family Registry Cohort
|
1UM1CA164920-01A1
|
$2,723,075
|
$2,723,075
|
JOHN, ESTHER
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry
|
5R01CA138638-02
|
$719,450
|
$719,450
|
JOHN, ESTHER
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
N01PC100140-004
|
$5,015,127
|
$5,015,127
|
GLASSER, SALLY
|
CANCER PREVENTION INSTITUTE OF CALIFORNI
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
5U54CA163060-02
|
$1,174,448
|
$246,634
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Computational Genomic Epidemiology of Cancer (CoGEC) Training Program
|
2R25CA094186-11
|
$500,447
|
$250,224
|
Elston, Robert
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S3
|
$4,849,180
|
$290,951
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S4
|
$74,396
|
$4,464
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Obesity-Related Insulin Resistance Signaling Pathway Factors and Colon Cancer
|
5R01CA136726-04
|
$457,798
|
$457,798
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
5P50CA150964-02
|
$2,250,301
|
$765,102
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Pathway Modeling of Complex Toxin Response and Energy Balance Systems in Cancer
|
5K07CA129162-05
|
$129,442
|
$129,442
|
Nock, Nora
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Genetic variants in the PI3K pathway in mammographic density and breast cancer
|
5K07CA136758-04
|
$127,915
|
$127,915
|
Thompson, Cheryl
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Genetic Predictors of AML Treatment Response
|
5R01CA133881-03
|
$560,885
|
$560,885
|
Aplenc, Richard
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
Total relevant funding to Biochemical Epidemiology for this search: $272,912,578
|